Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine.
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine.
复制标题
DOI:
10.1016/j.reprotox.2021.05.007
复制
发表时间:
2021-08
期刊:
影响因子:
--
通讯作者:
Lindemann C
中科院分区:
文献类型:
--
作者:
Bowman CJ;Bouressam M;Campion SN;Cappon GD;Catlin NR;Cutler MW;Diekmann J;Rohde CM;Sellers RS;Lindemann C
BNT162b2 is a vaccine developed to prevent coronavirus disease 2019 (COVID-19). BNT162b2 is a lipid nanoparticle formulated nucleoside-modified messenger RNA (mRNA) encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein locked in its prefusion conformation. A developmental and reproductive toxicity study was conducted in rats according to international regulatory guidelines. The full human BNT162b2 dose of 30 μg mRNA/dose (>300 times the human dose on a mg/kg basis) was administered intramuscularly to 44 female rats 21 and 14 days prior to mating and on gestation days 9 and 20. Half of the rats were subject to cesarean section and full fetal examination at the end of gestation, and the other half were allowed to deliver and were monitored to the end of lactation. A robust neutralizing antibody response was confirmed prior to mating and at the end of gestation and lactation. The presence of neutralizing antibodies was also confirmed in fetuses and offspring. Nonadverse effects, related to the local injection site reaction, were noted in dams as expected from other animal studies and consistent with observations in humans. There were no effects of BNT162b2 on female mating performance, fertility, or any ovarian or uterine parameters nor on embryo-fetal or postnatal survival, growth, physical development or neurofunctional development in the offspring through the end of lactation. Together with the safety profile in nonpregnant people, this ICH-compliant nonclinical safety data supports study of BNT162b2 in women of childbearing potential and pregnant and lactating women.
登录
查看更多内容
影响因子:
2.9
作者:
Banerjee J;Mullins E;Townson J;Playle R;Shaw C;Kirby N;Munnery K;Bourne T;Teoh TG;Dhanjal M;Poon L;Wright A;Lees C
通讯作者:
Lees C
影响因子:
13.8
作者:
Edlow AG;Li JZ;Collier AY;Atyeo C;James KE;Boatin AA;Gray KJ;Bordt EA;Shook LL;Yonker LM;Fasano A;Diouf K;Croul N;Devane S;Yockey LJ;Lima R;Shui J;Matute JD;Lerou PH;Akinwunmi BO;Schmidt A;Feldman J;Hauser BM;Caradonna TM;De la Flor D;D'Avino P;Regan J;Corry H;Coxen K;Fajnzylber J;Pepin D;Seaman MS;Barouch DH;Walker BD;Yu XG;Kaimal AJ;Roberts DJ;Alter G
通讯作者:
Alter G
影响因子:
120.7
作者:
Bianchi, Diana W.;Kaeser, Lisa;Cernich, Alison N.
通讯作者:
Cernich, Alison N.
影响因子:
9.8
作者:
Minkoff H;Ecker J
通讯作者:
Ecker J
影响因子:
1.3
作者:
Makris, Susan L.;Solomon, Howard M.;Wise, L. David
通讯作者:
Wise, L. David